Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/1981
06/17/1981EP0030496A1 Thiolated polypeptidic compound coming from a fragment of tetanic toxine, process for obtaining it and its applications
06/17/1981EP0030450A2 Hybrid cell line for producing complement-fixing, monoclonal antibody to human suppressor T cells, antibody, method of preparation of this antibody, diagnostic and therapeutic uses and pharmaceutical compositions comprising this antibody
06/17/1981EP0030449A2 Hybrid cell line for producing monoclonal antibody to human thymocyte antigen, antibody, method of preparation of this antibody, diagnostic and therapeutic uses and pharmaceutical compositions comprising this antibody
06/16/1981US4273865 Insolubilized biochemical materials
06/16/1981US4273762 Lyophilization process for live viral compositions
06/16/1981US4273756 Immunoassay for class specific antibodies
06/16/1981CA1103157A1 Method of producing antibodies
06/16/1981CA1103156A1 Method of producing tumor antibodies
06/16/1981CA1103155A1 Improved acellular vaccines containing capsular polysaccharides
06/10/1981EP0030199A2 Lyophilization process for live viral compositions
06/10/1981EP0030172A1 Process for preparing rhesus antigen, medicine and pharmaceutical compositions containing the antigen and administration forms
06/10/1981EP0030166A1 Vaccine composition for dental caries
06/10/1981EP0030063A2 Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines, process for preventing infectious bronchitis and infectious-bronchitis virus strains
06/09/1981US4272521 Purified immune serum globulin
06/09/1981US4272433 Polypeptides, protein carriers
06/09/1981CA1102696A1 Vaccine and method for immunotherapy of neoplastic disease
06/02/1981US4271147 Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
06/02/1981US4271146 Methods of using Chlamydia vaccine for preventing and treating bovine and ovine diseases
06/02/1981US4271145 Process for producing antibodies to hepatitis virus and cell lines therefor
06/02/1981US4271069 Beta-hCG preparation and method
05/1981
05/27/1981EP0029191A1 Protein PP 11, process for its isolation and its use
05/27/1981EP0029063A1 Detection of non-a, non-b hepatitis associated antigen
05/27/1981EP0029047A1 Combined inactivated vaccine, ready for administration and process for the preparation of such vaccine, active against egg production drop caused by adeno like viruses and against diseases caused by reo viruses
05/26/1981US4269825 New glycoprotein and process for isolating it
05/26/1981US4269821 Injecting submicroscopic particles of polymerized styrene or an acrylic monomer having adsorbed insulin in a liquid; vaccines; immunology; time-release agents
05/26/1981US4269765 Immune serum for diagnosis of cancer and preparation thereof
05/26/1981US4269764 Water-soluble polymers for biological injections by polymerizing an antigen and glutar aldehyde
05/20/1981EP0028987A2 Process for the in vitro culture of hepatitis B virus
05/20/1981EP0028902A1 Method for the preferential formation of hybrid cells making a desired antibody
05/20/1981EP0028815A2 The use of ricin and a pharmaceutical composition containing the same for increasing the immune response
05/20/1981EP0028814A2 Use of abrin for the manufacture of an immunopentiator
05/20/1981EP0028804A2 Vaccine and method for its preparation
05/20/1981EP0028795A2 Valproic acid conjugates and antibodies thereto
05/19/1981US4268435 Chorionic gonadotropin derived antigen for early pregnancy test and contraceptive vaccine
05/19/1981CA1101333A1 Preparation process of a protein concentrate containing immunological factors of lactic origin
05/13/1981EP0028567A2 Method of preparing hepatitis B surface antigen
05/13/1981EP0028563A1 Stabilizer for liquid vaccines and liquid vaccine containing said stabilizer
05/13/1981EP0028332A1 Beta-galactosyl-umbelliferone-labeled protein and polypeptide conjugates, and N-substituted 7-beta-galactosylcumarin-3-carboxamides
05/12/1981US4267235 Labels; immunoassay; crosslinking
05/12/1981US4267234 Polyglutaraldehyde synthesis and protein bonding substrates
05/12/1981US4267170 Methods of using chlamydia vaccine for preventing and treating bovine diseases
05/12/1981CA1100872A1 Method of producing intravenously injectable gamma globulin
05/12/1981CA1100869A1 Use of tri-iodo thyronine bonded to an enzyme in the determination of the concentration of tri-iodo thyronine
05/06/1981EP0028196A2 Glycolipid derivatives, their preparation and compositions comprising them
05/06/1981EP0028172A2 Anticolibacillary animal vaccine, preparation, application and used escherichia coli strains
05/06/1981EP0028132A2 Method of passively adsorbing immuno-reactive haptens to solid phases
05/06/1981EP0028092A2 A radiolabeled antibody composition, a kit for making same and a cancer or tumor-detection kit employing the composition
05/06/1981EP0027794A1 New and improved methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis
05/05/1981US4265873 Method for typing human leukocyte antigens
04/1981
04/30/1981WO1981001153A1 Eucaryote cells having a certain and concentration
04/30/1981WO1981001101A1 Improvements in or relating to vaccines
04/29/1981EP0027664A1 Use of the PP5 protein, its derivatives or the antibodies directed against that protein in contraception or in disruption of pregnancy
04/29/1981EP0027662A1 Eucaryotic cells and eucaryotic protoplasts with an amount of naked DNA introduced by lipid vesicles, process for their preparation and their use in the preparation of gene products
04/29/1981EP0027657A2 Process for producing antibodies to hepatitis virus and cell lines therefor
04/29/1981EP0027631A1 Flavin adenine dinucleotide-labeled protein and polypeptide conjugates
04/28/1981US4264764 Meningitis vaccine
04/28/1981US4264588 Vaccine for Clostridium perfringens type E enterotoxemia of rabbits
04/28/1981US4264587 Vaccine for preventing persistent feline leukemia viremia in cats
04/28/1981US4264571 Radioimmunoassay of thymosin α1
04/28/1981CA1100039A2 Hepatitis b antigen
04/28/1981CA1100038A2 Hepatitis b antigen
04/22/1981EP0027347A1 Feline infectious peritonitis virus, its preparation and vaccines containing it
04/22/1981EP0027249A1 Process for the preparation of influenza A virus vaccinating strains, vaccinating strain and vaccine containing it
04/21/1981CA1099635A1 Atoxic, immunogenic product of tetanus toxin
04/21/1981CA1099634A1 Vaccine stabilizer
04/15/1981EP0027088A1 Allergenic composition and process for its preparation
04/14/1981US4261975 Outer membrane of influenza virus attached to liposome using cationic surfactant
04/14/1981US4261974 Valproic acid immunogen conjugates and antibodies thereto
04/14/1981US4261973 Suppression of production of reaginic antibodies by injection of conjugate allergen with water-soluble polymer
04/14/1981CA1099258A1 Antigen-protein complex for blocking allergic reactions
04/08/1981EP0026209A1 A vaccine for combatting pleuropneumonia in pigs, and a process and a substrate for the aerobic fermentation of haemophilus pleuropneumoniae
04/07/1981US4260602 Hapten polysaccharide conjugate medicaments and method of use
04/02/1981WO1981000812A1 Vaccines from taxonomically similar organisms
04/01/1981EP0025842A2 Peptides, process for their preparation, their pharmaceutical compositions and their intermediates
03/1981
03/31/1981US4259324 Derivatives of thiopyranoses
03/31/1981US4259233 β-Galactosyl-umbelliferone-labeled protein and polypeptide conjugates
03/31/1981US4259232 Flavin adenine dinucleotide-labeled protein and polypeptide conjugates
03/31/1981CA1098515A1 Immunising and anti-infectious adjuvant agents constituted by esters of the n-acetyl-muramyl-l- alanyl-d-isoglutamine
03/25/1981EP0025745A1 Process for propagating human hepatitis A virus in in vitro cell culture
03/25/1981EP0025719A2 Gamma-globulin preparation for intravenous administration, process for production thereof and process for preparation of gamma-globulin of low anticomplementary activity
03/25/1981EP0025495A1 Lipophilic muramyl peptides, processes for their preparation and their use
03/24/1981US4258029 Synthetic adjuvants for stimulation of antigenic responses
03/24/1981CA1098032A1 Solid phase assay of non-human antibody
03/24/1981CA1098014A1 Method of indicating rheumatoid factors
03/18/1981EP0025379A2 Process for the preparation of suspensions or stable powders of stable microcapsules having a variable porosity, and products so obtained
03/18/1981EP0025275A2 Immunoglobulin-containing composition containing an aggregation preventing or aggregate dissociating agent for the immunoglobulin, and process for preparation thereof
03/18/1981EP0025116A1 Method of testing the inactivity of inoculates and harmlessness of blood products as well as the activity of chemotherapeutics or disinfectants against virus hepatitis and method for isolation of hepatitis virus antigen
03/17/1981US4256735 Immunologically active dipeptidyl saccharides and methods of preparation
03/17/1981US4256732 Oxidative rearrangement and ring scission
03/17/1981US4256631 Purification by fractional precipitation
03/17/1981US4256629 Antigen for early pregnancy test and contraceptive vaccine
03/11/1981EP0024956A2 Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype, method of preparing them and bacterial strains used in them
03/11/1981EP0024541A2 Vaccine for preventing persistent feline leukemia viremia in cats and process for preparing it
03/11/1981EP0024493A2 Multivalent pneumococcal vaccine
03/10/1981US4255537 Polymeric immunoregulatory agents containing half-amide/half carboxy/imide groups
03/10/1981US4255520 Process for the preparation of a rabies vaccine and vaccine obtained by this process
03/10/1981CA1097219A1 Respiratory syncytial vaccine
03/10/1981CA1097218A1 Hepatitis b surface antigen
03/05/1981WO1981000577A1 Nucleotidic sequence coding the surface antigen of the hepatitis b virus,vector containing said nucleotidic sequence,process allowing the obtention thereof and antigen obtained thereby
03/05/1981WO1981000517A1 Snake venom neurotoxin prophylaxis and therapy for poisonous organophosphates